Randomised controlled trial of salpingostomy versus salpingectomy for tubal pregnancy, the impact of future fertility

ISRCTN ISRCTN37002267
DOI https://doi.org/10.1186/ISRCTN37002267
Protocol serial number N0116151801
Sponsor European Surgery in Ectopic Pregnancy Study Group
Funders King's College Hospital NHS Trust R&D Consortium (UK), NHS R&D support funding (UK), Netherlands Organisation for Health Research and Development
Submission date
30/09/2005
Registration date
30/09/2005
Last edited
17/07/2015
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Pregnancy and Childbirth
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Mrs P J Hajenius
Scientific

Department of Obstetrics and Gynaecology
Academic Medical Center
University of Amsterdam
P.O. Box 22700
Amsterdam
1100 DE
Netherlands

Phone +31 (0)20 5663654
Email esep@amc.uva.nl

Study information

Primary study designInterventional
Study designRandomised active-controlled parallel-group trial
Secondary study designRandomised controlled trial
Scientific titleRandomised controlled trial of salpingostomy versus salpingectomy for tubal pregnancy, the impact of future fertility
Study acronymESEP study - European Surgery in Ectopic Pregnancy
Study objectivesWhether the potential advantage of salpingostomy (opening the fallopian tube to remove pregnancy) i.e. better fertility prognosis as compared to salpingectomy (removing the fallopian tube with the pregnancy), outweighs the potential disadvantages of this treatment i.e. persistent trophoblast and an increased risk for ectopic pregnancy.
Ethics approval(s)Ethics approval received from the local medical ethics committee
Health condition(s) or problem(s) studiedTubal pregnancy
InterventionSalpingostomy versus salpingectomy.
Intervention typeOther
Primary outcome measure(s)

Time to occurrence of a spontaneous intra uterine pregnancy.

Key secondary outcome measure(s)

Persistent trophoblast and repeat ectopic pregnancy. A cost-effectiveness analysis will be performed.

Completion date01/01/2010

Eligibility

Participant type(s)Patient
Age groupAdult
SexFemale
Target sample size at registration450
Key inclusion criteriaWomen with tubal pregnancy and a healthy contra-lateral tube.
Key exclusion criteria1. Aged less than 18 years
2. Shock
3. Pregnant after In Vitro Fertilisation and Embryo Transfer (IVF-ET)
4. Known tubal pathology
5. No fertility wish
Date of first enrolment01/10/2004
Date of final enrolment01/01/2010

Locations

Countries of recruitment

  • United Kingdom
  • Netherlands
  • Sweden

Study participating centre

Academic Medical Center
Amsterdam
1100 DE
Netherlands

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 26/04/2014 Yes No
Results article results 01/09/2015 Yes No
Protocol article protocol 26/06/2008 Yes No
Study website Study website 11/11/2025 11/11/2025 No Yes